Clinically approved IVIg delivered to the hippocampus with focused ultrasound promotes neurogenesis in a model of Alzheimer’s disease
Male
0301 basic medicine
Neurogenesis
Biological Availability
Mice, Transgenic
Plaque, Amyloid
blood–brain barrier
Hippocampus
03 medical and health sciences
Drug Delivery Systems
0302 clinical medicine
Alzheimer Disease
intravenous immunoglobulin
Animals
Humans
Ultrasonics
[SDV.NEU] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]
14. Life underwater
Microbubbles
Tumor Necrosis Factor-alpha
Immunoglobulins, Intravenous
MRI-guided focused ultrasound
Magnetic Resonance Imaging
3. Good health
neurogenesis
Disease Models, Animal
Treatment Outcome
Blood-Brain Barrier
Female
immunotherapy
Central Nervous System Agents
DOI:
10.1073/pnas.1908658117
Publication Date:
2020-12-07T21:35:43Z
AUTHORS (7)
ABSTRACT
Significance The efficacy of immunotherapy in Alzheimer’s disease is limited, partly because antibodies, administered peripherally, have poor access to the brain. Focused ultrasound (FUS) with microbubbles allows passage antibodies from blood In a mouse model disease, blood, and without FUS, reduced amyloid pathology. contrast, FUS was required deliver sufficient hippocampus effectively promote neurogenesis. Neurogenesis, regenerative process involved memory functions, impaired disease. Putative contributors stimulation neurogenesis include decrease proinflammatory cytokine TNF-α. holds potential increase for
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (96)
CITATIONS (67)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....